ALK and neoplasm: Therefore, to potentially complement sNGS, we validated the Idylla Genefusion assay for ALK, ROS1, and RET rearrangements and MET exon 14 skipping variant detection using 34 tumor samples that were previously orthogonally tested via FISH and NGS.